Publications by authors named "O Bechter"

Claim this Profile
T
The assembly of cancer-specific ribosomes by the lncRNA LISRR suppresses melanoma anti-tumor immunity.
Sonia Cinque, Yvessa Verheyden, Sara Adnane, Alessandro Marino, Sarah Hanache, Oliver Bechter

J Exp Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of time-of-day administration of immune checkpoint inhibitors on survival outcomes in patients with recurrent/metastatic head and neck cancer (R/M HNSCC): a retrospective cohort study.
Paulien Van Loocke, Benoit Beuselinck, Jeroen Meulemans, Sandra Nuyts, Robin Willaert, Oliver Bechter

Oral Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): A randomized open-label phase 2 study.
Paul Lorigan, Theresa Michelle Medina, Marta Nyakas, Annemie Rutten, Lynn G Feun, Oliver Edgar Bechter

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response.
Jieyi Xiong, Orian Bricard, Ingrid Arijs, Jonas Demeulemeester, Chen Gu, Oliver Bechter

Nucleic Acids Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment.
Francesca Lodi, Sam Vanmassenhove, Duojiao Chen, Bram Boeckx, Lucas Ferreira Maciel, Oliver Bechter

Cell Rep Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis